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Abstract
Background: Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder, which is usually caused
by de novo mutations in the MECP2 gene. More than 70% of the disease causing MECP2 mutations are eight
recurrent C to T transitions, which almost exclusively arise on the paternally derived X chromosome. About 10% of
the RTT cases have a C-terminal frameshift deletion in MECP2. Only few RTT families with a segregating MECP2
mutation, which affects female carriers with a phenotype of mental retardation or RTT, have been reported in the
literature. In this study we describe two new RTT families with three and four individuals, respectively, and review
the literature comparing the type of mutations and phenotypes observed in RTT families with those observed in
sporadic cases. Based on these observations we also investigated origin of mutation segregation to further improve
genetic counselling.
Methods: MECP2 mutations were identified by direct sequencing. XCI studies were performed using the X-linked
androgen receptor (AR) locus. The parental origin of de novo MECP2 frameshift mutations was investigated using
intronic SNPs.
Results: In both families a C-terminal frameshift mutation segregates. Clinical features of the mutation carriers vary
from classical RTT to mild mental retardation. XCI profiles of the female carriers correlate to their respective geno-/
phenotypes. The majority of the de novo frameshift mutations occur on the paternally derived X chromosome (7/9
cases), without a paternal age effect.
Conclusions: The present study suggests a correlation between the intrafamilial phenotypic differences observed
in RTT families and their respective XCI pattern in blood, in contrast to sporadic RTT cases where a similar
correlation has not been demonstrated. Furthermore, we found de novo MECP2 frameshift mutations frequently to
be of paternal origin, although not with the same high paternal occurrence as in sporadic cases with C to T
transitions. This suggests further investigations of more families. This study emphasizes the need for thorough
genetic counselling of families with a newly diagnosed RTT patient.
Background
Rett syndrome (RTT; MIM# 312750) is an X-linked
dominant neurodevelopmental disorder almost exclu-
sively affecting females. The incidence is about 1 in
10.000 female births [1]. The first loss-of-function muta-
tions in the methyl-CpG-binding protein 2 (MECP2;
MIM# 300005) were reported in RTT patients in 1999
[2]. Since then, more than 200 different MECP2 muta-
tions have been identified (RettBASE, http://mecp2.chw.
edu.au). About 70% of reported RTT cases have one of
the eight recurrent single basepair substitutions (mis-
sense or nonsense mutations), all of which are cytosine-
to-thymine (C > T) transitions affecting the cytosine of
the CpG dinucleotides. Small C-terminal deletions, with
one or both breakpoints located within the “deleted
prone region” (DPR) of exon 4, account for 10% of the
cases [3]. The vast majority of RTT cases are sporadic
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common C > T transition mutations arise almost exclu-
sively on the paternally derived X chromosome in spora-
dic cases [4-7]. So far, the parental origin of de novo
frameshift mutations has not been investigated in large
cohorts of RTT cases. Hemizygous males with de novo
or familial MECP2 mutations often have frameshift
mutations caused either by single-nucleotide deletions/
insertions or by small intragenic rearrangements [8,9].
The general knowledge regarding RTT families with
affected females is sparse as only 10 families have been
described in the literature [10-17]. Existence of such
families are usually explained by germline mosaicism or
skewed X chromosome inactivation (XCI) in the carrier
mothers, who are either asymptomatic or have mild
mental retardation (MR). While the eight recurrent C >
T transitions mutations often result in classical or atypi-
cal RTT in sporadic cases, the C-terminal deletions lead
to a broader spectrum of clinical features, from severe
encephalopathy in hemizygous males to hemizygous
females with classical RTT, mild MR and asymptomatic
carriers [18-20].
In this study we describe two new unrelated families
with frameshift mutations within the DPR, showing
large intrafamilial clinical variability, ranging from clas-
sic RTT to mild MR. Furthermore, we compare the type
of mutations observed in RTT families to those of
sporadic cases and we present our study on the parental
origin of de novo MECP2 frameshift mutations in our
RTT cohort.
Family A
Family A, (Figure 1A), consists of a mother (patient I: 1)
and her two daughters (patients II:1 and II:2).
Patient I:1 was married to a man with an IQ of 70 and
have given birth to two affected children. The oldest
daughter was removed to foster care at age 2.5 years,
the youngest daughter immediately after birth. There is
no information available about the childhood of the
mother and her regression status is unknown. She is
cognitively impaired with an IQ of 45. She has attended
a special school for children with learning disabilities.
Today she lives alone in a sheltered housing unit with
daily home care support. She speaks in full meaningful
sentences. She is able to read magazines, to write, to
knit, to bind shoe lashes and to read the clock. She can
manage addition and subtraction of money, but she can-
not administer her own finances. Within the frames of
known routines, she can manage her personal care, but
she cannot initiate or structure activities of daily living
or plan and perform simple sequential actions in unfa-
miliar settings. She is totally dependent on a structured
daily schedule. She is easily stressed by anxiety, which
occasionally requires medication. There has been no
report of seizures. She is overweight with normal height
and head circumference. She has a high thoracic kypho-
sis and a slight lumbar scoliosis. She walks up and down
the stairs, but the left foot leads downwards. Her hand
muscles are weak and hand movements are ritual. She
cannot perform the finger-to-nose-test. Breathing is
forced and she breathes only through the mouth.
Although she has subtle Rett-like symptoms, she does
not meet the required criteria for RTT [1,21].
Patient II:1 is the oldest daughter. At 17 months of
age her development corresponded to 12-14 months
and her head circumference was below the 1st percen-
tile. She was able to crawl, to walk with slight support
and used her hands with pincer grasp. At 2.5 years of
age she was removed to foster care for 5 years. During
this period she developed stereotypic hand movements
and some regression was noticed. Since 7 years of age
she has been living in institutions for mentally handi-
capped individuals. She has preserved some hand func-
tion, despite her stereotypic hand movements. She has
kyphosis. She walks only a few steps without support,
but walks steadily with support. She speaks no words,
but knows the sign for coffee and can use eye pointing.
She has normal height but she is overweight. She has
been treated with antiepileptic drugs for many years, but
she is now free of seizures, without medication. She has
a normal breathing pattern. She meets all the required
and one of the supportive criteria for classical RTT
[1,21].
Patient II:2 the younger daughter, was placed in an
institution for infants immediately after birth. At 5
months of age she was placed in foster care and she still
lives with the same family. At that time she smiled and
kept eye contact, but she was passive. She learned to sit
at age 8 months and to crawl at age 15 months. She
developed a sort of pincer grasp one year old and
babbled a lot. At this age her head circumference was
below the 2nd percentile. At age 20 months she started
kindergarten and some regression was noticed, but she
had almost full recovery afterwards. At age 2.5 years she
started walking independently and had a vocabulary
with small sentences. Since 4 years of age she has kept
her hands together in front of her, and since 7 years of
age she has been treated for epileptic seizures. At the
age of 12 years scoliosis was registered and she under-
went surgery 3 years later. At present she is able to sit
down, and get up from sitting and lying positions. She
can walk independently with small steps, but she is
more stable when pushing a wheel chair. She can walk
upstairs with support from the banister, but she needs
support on the other side while going downstairs. If in
mood she can take off her jacket. She has hand dys-
praxia. She is growth retarded with microcephaly. She
speaks with a high pitch voice and makes sentences up
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with a long latency. She meets the necessary criteria for
atypical RTT [1,21].
Family B
Family B, (Figure 1B), consists of a mother (patient I:1)
and her four children (including patient, II:2, II:3, II:4).
Patient I:1 is the mother of 4 children, from two
marriages. Neither of her husbands’ had neurological
handicaps or MR. One of the two daughters (II:2) from
her first marriage is affected, while the other is normal.
From the second marriage both children (patient II:3
and II:4) are affected. There is no information about
her developmental profile in childhood and her regres-
sion status is unknown. She has mild cognitive impair-
ment (IQ: 50-70), but she lives alone without any
social support. She has a normal expressive language
and she takes care of herself in daily living. She can
read magazines and can repeat what she has read. She
handles her own money and does her own shopping.
However, she does not have any deeper economic
insight. She speaks meaningful words and sentences.
She is characterized as clumsy. Her muscle tonus is
normal and there are no abnormal movements of the
hands. Her breathing is forced. No seizures or psychia-
tric symptoms have been reported. Height, weight and
head circumference are normal. She does not have sco-
liosis. She does not meet the required criteria for RTT
[1,21].
Female II:1 is the oldest daughter. There is no infor-
mation available, but apparently she has a normal
phenotype.
Figure 1 Pedigree of the two families with RTT and the electrophoretograms of the MECP2 frameshift mutations. (A) Family A, the
carrier mother (I:1) and her two affected children, (B) Family B, the mother (I:1) who is an obligate carrier and her four children. * Family
members who have not been tested for the MECP2 mutation in question. (C) Electrophoretograms showing the mutation, c.1157_1197del41,
identified in family A (D) Electrophoretograms showing the mutation, c.1159_delCCinsT, identified in family B.
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not been clinically examined by any of the authors and
the sparse clinical information is derived from the medi-
cal records. Her cognitive impairment and deterioration
of the motor function was first noticed in kindergarten.
Later full recovery was observed. In primary school, she
was diagnosed with MR due to cognitive dysfunction
and marked learning disability and received comprehen-
sive educational support. She has ataxia but she can
walk without support. Her muscle tonus is normal, but
she is clumsy. She has mild thoracic kyphosis. She has
mild hand dyspraxia and a tendency to ritual hand
movements. She also has tendency to teeth grinding and
her breathing is forced. She can speak in short meaning-
ful sentences, however her understanding is limited. No
seizures have been reported. She has an intensive eye
contact and delayed nociception. She fulfils the neces-
sary criteria for atypical RTT [1,21].
Patient II:3 is the youngest family member. During the
first years of life no developmental problems were
noted. When she started school a mild cognitive dys-
function with learning disability became evident. Today
she is still attending the ordinary school system, but
receives special educational support. She speaks in full
meaningful sentences, and understands simple messages.
She is dependent of known routines and can manage
her own personal care. She has no epilepsy and no clini-
cal gastrointestinal symptoms. Her growth has always
been normal. Her head circumference is normal. She
has a normal muscle tone, with no signs of focal neuro-
logical deficits. Her motor abilities are not well coordi-
nated, especially her fine motor skills. There are no
pathological orthopaedic signs and no stereotypies. Her
breathing is somewhat forced. She does not meet any of
the required criteria for RTT [1,21].
Patient II:4 is a boy. He was born to term with nor-
mal weight, height and head circumference. His devel-
opment was apparently normal during the first
months, but stagnated at 7-8 months of age. At age 12
months delayed motor development was noticed. He
could not sit without support, but he could raise his
upper body by support of his arms when lying in
prone position. He had general hypotonia as well as
marked truncal and fine motor ataxia. He was notably
happy and made good emotional contact. At age 20
months he vocalized “mama” and “papa”,h ew a sa b l e
to sit without support, could receive and throw a ball,
and finger feed himself. He had inappropriate scream-
ing spells. The ataxia and hypotonia gradually became
more prominent. The head circumference was below
the 2.5nd percentile. At this age he started having fre-
quent seizures and received antiepileptic medication.
Overall, there was no valid information about regres-
sion. CT and MRI scans of the brain and metabolic
investigations of organic acids, amino acidopathies and
lysosomal disorders as well as lactate and pyruvate in
blood and cerebrospinal fluid were normal. He had
normal karyotype and genetic test for Angelman syn-
drome was negative. When examined at age 6 years,
his development had stagnated since age 3. He still did
not stand or walk alone, but no loss of acquired motor
skills had been observed. He seemed less active than
before. He had a daily vocabulary of about 5 words,
w h i c hh eu s e da p p r o p r i a t e l y .T o d a yh eh a sm a r k e d
motor delay with hypotonia, pronounced ataxia and
epilepsy. During the last 2-3 years he has developed
hand wringing and dyspraxia. Furthermore, he has
some respiratory irregularities, marked teeth grinding
and he is growth retarded. Today he presents most of
the clinical signs of RTT[1,21].
Methods
Clinical evaluation
The patients have been clinically evaluated according to
the consensus RTT criteria described in 2001 [1], in
order to compare their clinical profiles with previously
published family members with RTT and further to the
current revised diagnostic criteria from 2010 [21].
Mutation detection and X inactivation studies
T h ee n t i r ec o d i n gMECP2 and the flanking intronic
sequences were sequenced as described earlier [22,23].
XCI studies were performed using DNA extracted
from peripheral blood leukocytes by investigation of
the methylation status of the highly polymorphic X-
linked androgen receptor (AR) locus [24]. The XCI
pattern was defined as skewed when the same X chro-
mosome was preferentially inactivated in more than
80% of the cells.
Determination of the parental origin de novo MECP2
frameshift mutations
We selected 24 presumably sporadic RTT patients with
ak n o w nMECP2 frameshift mutation caused by either
single-nucleotide deletion/insertion or small intragenic
rearrangement. The introns and the 3’ untranslated
region (3’-UTR) of MECP2 were sequenced to identify
single-nucleotide-polymorphisms (SNPs). Nine cases
were heterozygous for 6 different SNPs localized within
introns 2, 3 and 3’ UTR (Table 1). Allele-specific PCR
was possible in 7 cases and haplotyping of the normal
alleles was performed by direct sequencing. In two cases
cloning was necessary due to the location of the muta-
tion. A PCR-fragment spanning both the mutation and
the SNP was cloned into pGEM-T Esay Vector (Pro-
mega) and selected clones were sequenced. By genotyp-
ing the respective SNPs in the parents, parent-of-origin
was determined.
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Family A
Sequence analysis of the MECP2 gene in the mother
and her two daughters revealed a deletion of 41 base-
pairs (c.1157_1197del41), within the DPR in exon 4
(Figure 1C). This mutation is predicted to result in a
frameshift at codon 386 and subsequent premature
truncation of the MeCP2 protein five amino acids
downstream (p.L386fs). Results from the AR-assay indi-
cated a skewed XCI pattern in the mother (Family A,
I:1), whereas both daughters had random XCI pattern
(II:1, II:2) (Table 2).
Family B
The two maternal half-sisters and the brother had a
novel MECP2 frameshift mutation, c.1159_delCCinsT,
located in the DPR (Figure 1D). This mutation is pre-
dicted to result in addition of 21 amino acids followed
by a stop codon (p.P387fs). XCI studies showed random
XCI patterns in the mother (Family B, I:1) and her old-
est affected daughter (II:2), while the second affected
daughter had a skewed XCI pattern (II:3) (Table 2).
Parental origin of the de novo MECP2 frameshift
mutations
The parental origins were determined in 9 cases with
frameshift mutations (Table 1). All five C-terminal fra-
meshift deletions and two mutations generated by small
intragenic rearrangements (c.32_50delins11 and
c.766_779dup14) were of paternal origin. Two mutations
with a deletion of a single cytosine base (c.215delC and
c.808delC) were of maternal origin. The mothers’ of
these two patients did not carry the respective muta-
tions. The parents’ ages at the time of the patients’ birth
are listed in Table 1.
Discussion
Here we report two new families with frameshift muta-
tions located in the DPR of the MECP2. The phenotypes
of the affected individuals range from classical RTT to
milder cognitive impairment with subtle Rett-like symp-
toms. Thus, some of these family members represent
the clinical link between RTT and asymptomatic carriers
of a MECP2 mutation. In general, the frameshift muta-
tions in the DPR are commonly reported in RTT
patients [19,20]. These patients often fulfil the clinical
criteria for classical RTT or a variant form, although
few cases have been reported with very mild clinical fea-
tures [25]. In the extremely mild cases, like some of the
present cases (family A, patient I:1 and family B, patient
II:3), the detection of a known MECP2 mutation is
often required to identify the subtle clinical signs as
being RTT-like symptoms. Although no clear correla-
tion is demonstrated between genotype, phenotype and
XCI in sporadic RTT patients, it seems that a correla-
tion exists in families with RTT females, where an
MECP2 mutation is segregating (Table 3). We made a
similar observation in family A, where the mother had a
skewed XCI, most likely in favour of the normal allele,
which could explain her mild cognitive impairment with
subtle Rett-like symptoms, whereas both her daughters
had random XCI pattern and were diagnosed with RTT.
In family B, the mother who was an obligate carrier did
not want to be tested for the mutation. She had random
XCI, which was not in accordance with her obligate car-
rier status or her mild phenotype. A plausible explana-
tion is that the XCI pattern observed in her blood is not
representative for the critical tissue affected in RTT.
Table 1 The Parental origin of de novo MECP2 frameshift mutations
Case no Age of mother
a
(Years)
Age of father
a
(Years)
MECP2
mutation
b
Intergenic
SNP
b
Parental
origin
RTT22 31 32 c.215delC c.1461+1737G > A Maternal
RTT55 40 43 c.32_50delins11 c.1461+878G > C Paternal
RTT27 21 25 c. 766_779dup14 c.378-916A > G Paternal
RTT12 19 30 c.808delC c.378+266C > T Maternal
RTT1 29 24 c.1150_1187del38 c.378+648A > G Paternal
RTT35 30 32 c.1156_1199del44 c.378+266C > T Paternal
RTT16 26 28 c. 1157_1197del41 c.1461+1737G > A Paternal
RTT31 24 28 c.1164_1204del44 c.378+266C > T Paternal
RTT8 23 27 c.1168_1196del29 c.378+266C > T Paternal
a The parents’ age at the time of the RTT patient’s birth
b All nucleotides were numbered according to NCBI Reference Sequence: NM_004992.3
Table 2 The X chromosome inactivation patterns
obtained from AR assays
AR assay
Family A, I:1 A270:A273 (12:88) Family B, I:1 A271:A277 (51:49)
Family A, II:1 A270:A273 (56:44) Family B, II:2 A274:A277 (46:54)
Family A, II:2 A270:A273 (63:37) Family B, II:3 A269:A271 (20:80)
The alleles (A) are indicated with the size of the PCR fragments in base pair.
The allele sizes in Family B, indicates the presence of a recombination event.
Note that the two half-sisters in family B, does not have the same father.
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Another explanation, which cannot be ruled out without
a mutation analysis, is that she has gonadal mosaicism
and her mild retardation is due to other factors. The
XCI patterns of the two half-sisters were in accordance
with their different clinical presentations as the youngest
sister with extremely mild symptoms had skewed XCI.
The phenotype of the boy has changed with time and at
present he meets most of the criteria for a variant form
of RTT. However, he has a milder phenotype than
expected and does not have neonatal encephalopathy,
which has been reported in male with C-terminal dele-
tions in DPR [26]. The large intrafamilial clinical varia-
bility observed in family B, suggests the presence of
modifying genetic or epigenetic factors, other than XCI.
Four families with deletions in the DPR have pre-
viously been reported [10,26-28]. In three of these
families the mothers were asymptomatic carriers with
skewed XCI pattern presumably in favour of the normal
allele (Table 3). The fourth family included three gen-
erations (3 females and 2 males) with a 1164_1207del44
mutation [10]. The grandmother had learning disability,
the mother had cognitive delay, whereas the grand-
daughter had classical RTT. Both males presented with
RTT-like features including deceleration of head growth
and transient presence of stereotypic hand movements.
The XCI patterns obtained for each of the female family
members correlated with their respective phenotypes
(Table 3).
The present study suggests that there may be a group
of unrecognized asymptomatic or mildly affected
mothers carrying a MECP2 frameshift mutation. Like
the present families, these carrier mothers may not be
recognized until they give birth to children with RTT.
Table 3 Families with RTT in females and MECP2 mutation carrier females without RTT
MECP2 Mutation Phenotype male Phenotype Female Phenotype Mother Rf
Families with RTT in females
p.R106W c.316C >
T
Two half sisters Classic RTT Asympt. mutation negative [15]
p.T158M c.473C >
T
Congenital encephalopathy Classic RTT Asympt. mutation carrier, SXCI [14]
p.R133C c.397C >
T
RTT variant Classic RTT Mild MR, mutation carrier,
SXCI
[13]
p.S134C c.401C >
G
RTT variant RTT variant, random XCI Asympt. mutation carrier, SXCI [11]
P.R168X c.502C > T Two sisters Classic RTT Asympt. mutation carrier, SXCI [16]
p.V288X c.806delG Congenital encephalopathy Three females Mother; mild MR, SXCI Maternal
sister; classic RTT Daughter; classic RTT
Grandmother; Asympt.,
mutation negative, random
XCI
[16]
p.G163fs
c.488_489del
Congenital encephalopathy Classic RTT Asympt. mutation negative [12]
p.G252fs c.754insC Congenital encephalopathy Classic RTT Asympt. mutation negative [17]
p.L386fs
c.1157_1197del41
Two sisters Classic RTT, random XCI RTT
Variant, random XCI
Mild MR, mutation carrier,
SXCI
Present
case
p.P387fs
c.1159_delCCinsT
RTT variant Two sisters RTT Variant, random XCI Mild MR,
SXCI
Mild MR, mutation?, random
XCI
Present
case
p.P388fs
c.1164_1207del44
Two males Uncle and nephew
RTT variants
Two females Mother mild MR, SXCI Daughter
classic RTT
Grandmother, mild MR,
mutation carrier, SXCI
[10]
g.58483_65650del;
g.65664_66958del
Congenital encephalopathy Classic RTT Mild MR, mutation carrier,
SXCI
[30]
MECP2 mutation carrier females without RTT
p.T158M c.473C >
T
Two brothers Congenital
encephalopathy
Asympt. mutation carrier, SXCI [31]
p.P322S c.964C > T RTT variant Mild MR, mutation carrier,
random XCI
[32]
p.P380fs
c.1140del86
Two brothers MR, neurologic
symptoms, dimorphic features
Asympt. mutation carrier, XCI
not available
[28]
p.P384fs
c.1154del32
Congenital encephalopathy Asympt. mutation carrier, SXCI [26]
p.L386fs
c.1158del44
RTT variant Asympt. mutation carrier, SXCI [27]
MR, presented with mental retardation; SXCI, Skewed X chromosome inactivation
All nucleotides were numbered according to NCBI Reference Sequence: NM_004992.3
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with RTT have a frameshift mutation, and a clear corre-
lation exists between the XCI profile in blood and the
phenotypes of the respective family members. It is
known from cases with sporadic RTT, that over 70%
have the C > T transition, (RettBASE, http://mecp2.chw.
edu.au), which are almost exclusively of paternal origin
[4-7] and the blood XCI profiles do not correlate with
their phenotypes [29]. Therefore another segregation
mechanism may exist for MECP2 frameshift mutations,
which can influence a more favourable phenotype, e.g.
XCI, which could explain the over-representation of fra-
meshift mutations in the families with RTT. It was not
possible to determine the parental origin of the muta-
tions in our families. As the parental origin of de novo
frameshift MECP2 mutations are only scarcely reported,
we attempted to determine parental origin of de novo
frameshift mutations in our RTT cohort. Out of 24
sporadic RTT cases with frameshift mutations we could
determine the parental origin in 9. Surprisingly, we
found that the majority of the de novo frameshift muta-
tions occurred on the paternally derived X chromosome
(7/9 cases) without paternal age effect. All five cases
with C-terminal deletions were of paternal origin, which
suggests that the primary mutational event in family A
h a do c c u r r e do nt h em o t h e r ’s paternal X chromosome.
The two mutations with maternal origin were both dele-
tions of a single cytosine (c.215delC and c. 808delC)
predicted to lead to early premature truncation of the
MeCP2. The mothers’ of these patients were both nega-
tive for the respective mutations. Whether single base
pair deletions are more frequently maternally derived is
yet to be investigated. In two previously reported cases
with sporadic RTT, the frameshift mutations (c.806delG
and c.677insA) occurred on the maternally derived X
chromosome [5,7]. Together these results indicate that
f r a m e s h i f tm u t a t i o n si n v o l v i n go n l yas i n g l eb a s ep a i r
have a tendency to be of maternal origin than first
anticipated, but as listed in Table 3 the familial muta-
tions are not predominated by single base pair deletions
or insertions. The underlying mechanisms for the sex
bias among de novo MECP2 mutations in RTT patients
require further investigation, but the sparse number of
reported males with a pathogenic MECP2 mutation and
families with RTT seem to support ours and others
findings of paternal origin [4-7]. Furthermore, these
findings also indicate that the existence of a large num-
ber of unknown MECP2 carriers is probably unlikely.
The recurrence risk of RTT is low, but an empirical
estimation should be taken with caution. Based on the
Danish and the Norwegian RTT populations with identi-
fied MECP2 mutations, the incidence of the RTT
families compared to the sporadic cases is approximately
1:150 (unpublished data). As investigation of the
mothers’ XCI status cannot provide sufficient evidence
to exclude a carrier status due to mosaicism, determina-
tion of the paternal origin of the MECP2 mutation,
when possible, may give further information on whether
a new RTT case is sporadic. The knowledge of rare
mutation events described in the present families under-
lines importance of genetic counselling and discussion
of the possibility of prenatal diagnosis in families with a
proband who has a MECP2 mutation.
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